EVENTS | VIEW CALENDAR
Low vitamin D among the elderly is associated with significant decline in cognition, dementia
SACRAMENTO, Calif.—Vitamin D insufficiency among the elderly is highly correlated with accelerated cognitive decline and impaired performance, particularly in domains such as memory loss that are associated with Alzheimer’s disease and dementia, researchers with the UC Davis Alzheimer’s Disease Center and Rutgers University have found. The effect is “substantial,” with individuals with low vitamin D declining at a rate three times faster than those with adequate vitamin D levels.
The researchers said their findings amplify the importance of identifying vitamin D insufficiency among the elderly, particularly high-risk groups such as African-Americans and Hispanics, who are less able to absorb the nutrient from its most plentiful source—sunshine. Among those groups and other darker-skinned individuals, low vitamin D should be considered a risk factor for dementia, they said.
The research is published online today in JAMA Neurology, a JAMA Network journal.
“Independent of race or ethnicity, baseline cognitive abilities and a host of other risk factors, vitamin D insufficiency was associated with significantly faster declines in both episodic memory and executive function performance,” said Joshua Miller, professor in the UC Davis Department of Pathology and Laboratory Medicine at the time when the research was conducted and now professor and chair of the Department of Nutritional Sciences at Rutgers University.
“This work, and that of others, suggests that there is enough evidence to recommend that people in their 60s and older discuss taking a daily vitamin D supplement with their physicians,” Miller said.
“Even if doing so proves to not be effective, there’s still a very low health risk to doing it,” he said.
The large study was conducted in nearly 400 racially and ethnically diverse men and women in Northern California participating in longitudinal research at the Alzheimer’s Disease Center in Sacramento, Calif. Fifty percent of participants were Caucasian and 50 percent were African-American or Hispanic. The participants had a mean age of 76 and were either cognitively normal, or had mild cognitive impairment or dementia.
The participants’ serum vitamin D status was measured at the beginning of the study. Vitamin D deficiency and insufficiency were prevalent among all of the study participants. Overall, 26 percent were deficient and 35 percent were insufficient. Among Caucasians, 54 percent had low vitamin D, compared with 70 percent of African-Americans and Hispanics.
Over five years of follow-up, vitamin D deficient individuals experienced cognitive declines that were two-to-three times faster than those with adequate serum vitamin D levels. In other words, it took only two years for the deficient individuals to decline as much as their counterparts with adequate vitamin D declined during the five-year follow-up period.
“We expected to see declines in individuals with low vitamin D status,” said Charles DeCarli, director of the Alzheimer’s Disease Center. “What was unexpected was how profoundly and rapidly [low vitamin D] impacts cognition.”
Exposing the skin to sunlight is the major source of vitamin D. Racial and some ethnic minorities are at greater risk of low vitamin D because the higher concentration of melanin that makes their skin darker—and protects against skin cancer in sunny climates—also inhibits synthesis of vitamin D.
Diet is the other major source of vitamin D. Dietary vitamin D is obtained particularly through dairy consumption. The intake of dairy products is especially low among minority groups, with only 6.5 percent of African-Americans and 11 percent of Mexican- Americans nationwide consuming the recommended three daily servings of dairy products, the study says.
“I don’t know if replacement therapy would affect these cognitive trajectories. That needs to be researched and we are planning on doing that,” DeCarli said.
“This is a vitamin deficiency that could easily be treated and that has other health consequences. We need to start talking about it. And we need to start talking about it, particularly for people of color, for whom vitamin D deficiency appears to present an even greater risk,” he said.
Other study authors include Danielle J. Harvey, Laurel Beckett, Ralph Green, Sarah Farias, Bruce Reed, John Olichney and Dan Mungas, all of UC Davis.
The study was funded by a grant from the National Institutes of Health P30 AG010129 to DeCarli.
The UC Davis Alzheimer's Disease Center is one of only 27 research centers designated by the National Institutes of Health's National Institute on Aging. The center's goal is to translate research advances into improved diagnosis and treatment for patients while focusing on the long-term goal of finding a way to prevent or cure Alzheimer's disease. Also funded by the state of California, the center allows researchers to study the effects of the disease on a highly diverse population.
The National Institute on Aging funds Alzheimer’s Disease Centers (ADCs) at major medical institutions across the United States. Researchers at these centers are working to translate research advances into improved diagnosis and care for people with Alzheimer’s disease while focusing on the program’s long-term goal—finding a way to cure and possibly prevent Alzheimer's.
Areas of investigation range from the basic mechanisms of Alzheimer's to managing the symptoms and helping families cope with the effects of the disease. Center staff conduct basic, clinical, and behavioral research and train scientists and healthcare providers.
Although each center has its own area of emphasis, a common goal of the ADCs is to enhance research on Alzheimer's disease by creating a network that shares new ideas and research results. Collaborative studies draw upon the expertise of scientists from many different disciplines.